foscarnet has been researched along with Lung Diseases in 3 studies
Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.
Lung Diseases: Pathological processes involving any part of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present the case of a lung transplant recipient with disseminated crystal precipitation, and granulomatous and fibrinous inflammation after therapy with foscarnet (Foscavir; AstraZeneca, Zug, Switzerland) for recurring ganciclovir-resistant cytomegalovirus (CMV) reactivation." | 7.78 | Crystal precipitation and granulomatous inflammation in multiple organs after foscarnet therapy in a lung transplant recipient. ( Boehler, A; Gaspert, A; Schuurmans, MM; Tischler, V, 2012) |
| "We present the case of a lung transplant recipient with disseminated crystal precipitation, and granulomatous and fibrinous inflammation after therapy with foscarnet (Foscavir; AstraZeneca, Zug, Switzerland) for recurring ganciclovir-resistant cytomegalovirus (CMV) reactivation." | 3.78 | Crystal precipitation and granulomatous inflammation in multiple organs after foscarnet therapy in a lung transplant recipient. ( Boehler, A; Gaspert, A; Schuurmans, MM; Tischler, V, 2012) |
| "The initial and maintenance treatment of CMV retinitis must be individualized based on the characteristics of the lesions, including location and extent, specific patient factors, and characteristics of available therapies among others." | 1.30 | Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. ( Benson, CA; Deutsch, TA; Dieterich, DT; Drew, WL; Feinberg, J; Friedberg, DN; Griffiths, PD; Hardy, WD; Holland, GN; Jabs, DA; Jacobson, MA; Kessler, HA; Polis, MA; Powderly, WG; Spector, SA; Walmsley, S; Whitley, RJ, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tischler, V | 1 |
| Schuurmans, MM | 1 |
| Boehler, A | 1 |
| Gaspert, A | 1 |
| Whitley, RJ | 1 |
| Jacobson, MA | 1 |
| Friedberg, DN | 1 |
| Holland, GN | 1 |
| Jabs, DA | 1 |
| Dieterich, DT | 1 |
| Hardy, WD | 1 |
| Polis, MA | 1 |
| Deutsch, TA | 1 |
| Feinberg, J | 1 |
| Spector, SA | 1 |
| Walmsley, S | 1 |
| Drew, WL | 1 |
| Powderly, WG | 1 |
| Griffiths, PD | 1 |
| Benson, CA | 1 |
| Kessler, HA | 1 |
| Brochard, L | 1 |
| Salmeron, S | 1 |
| Herve, P | 1 |
| Petitpretz, P | 1 |
| Boissonnas, A | 1 |
| Simonneau, G | 1 |
| Duroux, P | 1 |
3 other studies available for foscarnet and Lung Diseases
| Article | Year |
|---|---|
Crystal precipitation and granulomatous inflammation in multiple organs after foscarnet therapy in a lung transplant recipient.
Topics: Adult; Antiviral Agents; Crystallization; Cytomegalovirus Infections; Foscarnet; Granuloma; Heart Di | 2012 |
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cytomegalovirus | 1998 |
[Importance of Foscarnet in the treatment of cytomegalovirus pneumopathy in a patient with acquired immunodeficiency syndrome].
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; | 1986 |